<DOC>
	<DOCNO>NCT02495649</DOCNO>
	<brief_summary>The purpose study evaluate add value PET-CT [ 18F ] FDOPA tracer Assessment Myocardial Sympathetic Denervation patient suspect Parkinson 's disease . The investigator expect see normal value uptake ratio [ 18F ] FDOPA , patient synuclein underline pathology previously know cardiovascular disease ( history high blood pressure take medication influence sympathetic system- exclusion criterion ) . Low value uptake ratio presume find patient diagnose Parkinson 's disease synuclein pathology . The expected normal ratio Heart/liver uptake value determine scan patient refer [ 18F ] FDOPA scan find normal [ 18F ] FDOPA scan basal ganglion cardiovascular disease .</brief_summary>
	<brief_title>Evaluation Myocardial Sympathetic Denervation Parkinson 's Disease Using 18FFDOPA</brief_title>
	<detailed_description>L-3,4-dihydroxy-6- [ 18F ] fluoro-phenylalanine ( [ 18F ] FDOPA ) might useful tracer assess myocardial sympathetic denervation Parkinson 's disease ( PD ) Patients . Compared routinely use I123 MIBG scan , [ 18F ] FDOPA seem advantage follow reason : 1. meta-iodobenzylguanidine ( MIBG ) false analog norepinephrine [ 18F ] FDOPA radiolabelled form DOPA , direct precursor dopamine subsequently convert norepinephrine 2 . 123I MIBG , un-like norepinephrine , dose undergo intracellular metabolism ( 19 ) [ 18F ] FDOPA undergo complex intracellular metabolism ( 17 ) 3 . Studies show I123 MIBG reuptake almost exclusive uptake mechanism 1 . Uptake-2 mechanism 123I-MIBG myocardium significant . Reuptake norepinephrine ( NE ) synaptic cleft mainly uptake 1 system also small amount uptake 2 system . The investigator assumption double mechanism reuptake increase concentration [ 18F ] FDOPA well imaging</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>1 . Age â‰¥ 18 2 . Signed Informed Consent 3 . Patients refer Fdopa scan basal ganglia evaluation Parkinson 's disease extra pyramidal motor disorder . 4 . Patients diagnose Parkinson 's disease . 1 . Age &lt; 18 2 . Previous diagnosed Heart Disease . 3 . History High blood pressure . 4 . On medication influence sympathetic system .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>